Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies

The enormous sequence diversity between human immunodeficiency virus type 1 (HIV-1) strains poses a major roadblock for generating a broadly protective vaccine. Many experimental HIV-1 vaccine efforts are therefore aimed at eliciting broadly neutralizing antibodies (bNAbs) that are capable of neutra...

Full description

Bibliographic Details
Main Authors: Mitch Brinkkemper, Kwinten Sliepen
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/7/3/76